Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02560779
Title Trial of TRC105 and Sorafenib in Patients With HCC
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Indications

hepatocellular carcinoma

Therapies

Carotuximab + Sorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.